Financial Snapshot

Revenue
$189.3M
TTM
Gross Margin
72.96%
TTM
Net Earnings
-$4.150M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
122.03%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$106.3M
Q4 2024
Cash
Q4 2024
P/E
-37.65
Nov 29, 2024 EST
Free Cash Flow
$17.25M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue $245.9M $221.7M $139.9M $102.4M $72.64M $62.80M $54.69M $59.23M $108.0M $58.40M $19.60M $3.900M $3.900M $1.500M $0.00 $1.600M $2.200M $2.000M $5.400M
YoY Change 10.92% 58.51% 36.65% 40.9% 15.67% 14.82% -7.67% -45.15% 84.93% 197.96% 402.56% 0.0% 160.0% -100.0% -27.27% 10.0% -62.96%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue $245.9M $221.7M $139.9M $102.4M $72.64M $62.80M $54.69M $59.23M $108.0M $58.40M $19.60M $3.900M $3.900M $1.500M $0.00 $1.600M $2.200M $2.000M $5.400M
Cost Of Revenue $68.93M $57.90M $33.21M $28.17M $19.93M $16.94M $16.86M $17.26M $32.40M $19.50M $7.000M $1.400M $1.300M $600.0K $0.00 $1.600M $2.200M $1.900M $4.600M
Gross Profit $177.0M $163.8M $106.6M $74.18M $52.71M $43.80M $37.83M $41.97M $75.60M $38.90M $12.60M $2.600M $2.600M $900.0K $0.00 $0.00 $100.0K $100.0K $800.0K
Gross Profit Margin 71.97% 73.88% 76.25% 72.48% 72.56% 69.74% 69.17% 70.86% 70.0% 66.61% 64.29% 66.67% 66.67% 60.0% 0.0% 4.55% 5.0% 14.81%

Selling, General & Admin Expense

Research & Development

No data

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Selling, General & Admin $86.60M $17.72M $4.952M $171.0K $1.600M $31.43M $39.99M $84.48M $36.80M $11.10M $1.800M $2.000M $1.600M $1.700M $200.0K $600.0K $500.0K -$1.300M
YoY Change 388.77% 257.79% 2795.91% -89.31% -94.91% -21.39% -52.67% 129.57% 231.53% 516.67% -10.0% 25.0% -5.88% 750.0% -66.67% 20.0% -138.46%
% of Gross Profit 52.87% 16.61% 6.68% 0.32% 3.65% 83.09% 95.27% 111.75% 94.6% 88.1% 69.23% 76.92% 177.78% 600.0% 500.0% -162.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.58M $40.16M $23.04M $17.79M $14.54M $10.83M $11.71M $11.98M $10.80M $9.480M $2.270M $380.0K $290.0K $120.0K $10.00K $30.00K $50.00K $50.00K $200.0K
YoY Change 11.01% 74.31% 29.54% 22.34% 34.18% -7.47% -2.28% 10.98% 13.89% 317.62% 497.37% 31.03% 141.67% 1100.0% -66.67% -40.0% 0.0% -75.0%
% of Gross Profit 25.19% 24.52% 21.6% 23.98% 27.58% 24.74% 30.95% 28.55% 14.28% 24.37% 18.02% 14.62% 11.15% 13.33% 50.0% 50.0% 25.0%
Operating Expenses $158.8M $101.1M $75.50M $52.03M $46.25M $43.16M $51.99M $107.7M $46.20M $12.60M $2.200M $3.100M $2.500M $1.700M $300.0K $600.0K $500.0K -$1.000M
YoY Change 57.11% 33.88% 45.1% 12.49% 7.18% -16.99% -51.74% 133.17% 266.67% 472.73% -29.03% 24.0% 47.06% 466.67% -50.0% 20.0% -150.0%
Operating Profit $1.115M $5.000M $5.573M -$1.321M $673.0K -$2.455M -$5.323M -$10.02M -$32.12M -$7.300M $0.00 $400.0K -$500.0K -$1.600M -$1.700M -$300.0K -$500.0K -$400.0K $1.800M
YoY Change -77.7% -10.28% -521.88% -296.29% -127.42% -53.88% -46.86% -68.82% 340.06% -100.0% -180.0% -68.75% -5.88% 466.67% -40.0% 25.0% -122.22%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Interest Expense -$6.600M -$2.946M -$7.869M -$4.023M -$528.2K -$1.349M -$1.004M $3.438M -$1.000M $200.0K -$2.800M $0.00 $0.00 $0.00 $0.00 $0.00 -$2.000M
YoY Change 124.03% -62.56% 95.6% 661.65% -60.84% 34.29% -129.21% -443.83% -600.0% -107.14% -100.0%
% of Operating Profit -132.0% -52.86% -597.77% -700.0% -111.11%
Other Income/Expense, Net $0.00 $1.431M $0.00 -$210.0K -$1.906M $0.00 -$88.42K -$161.3K -$300.0K -$100.0K
YoY Change -100.0% -100.0% -88.98% -100.0% -45.19% -46.22% 200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Pretax Income -$6.654M -$2.700M $2.935M -$9.329M -$3.575M -$6.881M -$6.460M -$20.67M -$66.81M -$18.60M -$1.500M -$2.500M -$500.0K -$1.700M -$1.700M $0.00 -$1.500M -$400.0K -$200.0K
YoY Change 146.44% -191.99% -131.46% 160.95% -48.05% 6.52% -68.75% -69.06% 259.19% 1140.0% -40.0% 400.0% -70.59% 0.0% -100.0% 275.0% 100.0%
Income Tax $109.0K $100.0K -$1.904M -$3.155M $128.0K $208.6K $100.8K -$341.3K -$8.306M $1.100M -$100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K -$200.0K $0.00
% Of Pretax Income -64.87%
Net Earnings -$6.763M -$2.800M $4.839M -$6.174M -$4.572M -$5.729M $14.54M -$17.75M -$58.50M -$19.70M -$1.400M -$2.500M -$500.0K -$1.700M -$1.600M $1.300M -$1.800M $700.0K -$300.0K
YoY Change 141.54% -157.86% -178.38% 35.04% -20.19% -139.4% -181.94% -69.67% 196.97% 1307.14% -44.0% 400.0% -70.59% 6.25% -223.08% -172.22% -357.14% -333.33%
Net Earnings / Revenue -2.75% -1.26% 3.46% -6.03% -6.29% -9.12% 26.59% -29.96% -54.17% -33.73% -7.14% -64.1% -12.82% -113.33% 81.25% -81.82% 35.0% -5.56%
Basic Earnings Per Share -$0.16 -$0.07
Diluted Earnings Per Share -$0.16 -$0.07 $130.0K -$202.8K -$201.2K -$276.5K $771.2K -$941.2K -$3.294M -$1.71 -$0.23 -$0.73 -$0.17 -$0.55 -$0.78 $13.00 -$48.74 -$10.34 -$10.92

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Cash & Short-Term Investments $17.20M $8.516M $34.61M $29.23M $9.708M $3.359M $2.630M $5.268M $39.00M $12.50M $3.300M $300.0K $600.0K $2.800M $100.0K $0.00 $100.0K $0.00
YoY Change 101.97% -75.4% 18.42% 201.06% 189.0% 27.72% -50.07% -86.49% 212.0% 278.79% 1000.0% -50.0% -78.57% 2700.0% -100.0%
Cash & Equivalents
Short-Term Investments $0.00
Other Short-Term Assets $3.800M $1.052M $1.430M $552.0K $604.0K $379.3K $637.6K $1.171M $200.0K $100.0K $0.00 $0.00 $100.0K $0.00 $0.00 $300.0K $1.100M $100.0K
YoY Change 261.22% -26.43% 159.06% -8.61% 59.25% -40.51% -45.56% 485.59% 100.0% -100.0% -100.0% -72.73% 1000.0%
Inventory $18.40M $15.59M $9.253M $6.415M $3.578M $4.374M $7.591M $6.314M $5.400M $1.200M $600.0K $0.00 $100.0K $0.00
Prepaid Expenses
Receivables $26.00M $16.38M $11.94M $9.089M $9.357M $9.712M $7.383M $18.68M $18.40M $6.600M $2.300M $700.0K $400.0K $0.00 $100.0K $100.0K $100.0K $300.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $65.40M $41.54M $57.23M $45.28M $23.25M $17.83M $18.24M $31.43M $63.10M $20.50M $6.200M $1.000M $1.100M $2.900M $200.0K $400.0K $1.300M $500.0K
YoY Change 57.45% -27.43% 26.39% 94.79% 30.42% -2.28% -41.97% -50.18% 207.8% 230.65% 520.0% -9.09% -62.07% 1350.0% -50.0% -69.23% 160.0%
Property, Plant & Equipment $53.40M $33.50M $23.51M $16.67M $14.72M $16.20M $16.00M $26.72M $17.40M $8.200M $1.300M $1.400M $1.100M $200.0K $100.0K $100.0K $200.0K $700.0K
YoY Change 59.42% 42.5% 41.03% 13.2% -9.12% 1.25% -40.1% 53.54% 112.2% 530.77% -7.14% 27.27% 450.0% 100.0% 0.0% -50.0% -71.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.700M $57.18M $504.0K $641.0K $71.00K $93.85K $60.13M $98.50K $100.0K $100.0K $1.100M $200.0K $0.00 $0.00 $0.00 $500.0K $1.200M $0.00
YoY Change -97.03% 11245.44% -21.37% 802.82% -24.35% -99.84% 60948.86% -1.5% 0.0% -90.91% 450.0% -100.0% -58.33%
Total Long-Term Assets $182.0M $90.68M $51.34M $26.78M $18.41M $20.26M $80.43M $82.30M $97.90M $16.10M $2.400M $1.600M $1.200M $200.0K $100.0K $700.0K $1.400M $1.000M
YoY Change 100.71% 76.62% 91.7% 45.46% -9.13% -74.81% -2.28% -15.93% 508.07% 570.83% 50.0% 33.33% 500.0% 100.0% -85.71% -50.0% 40.0%
Total Assets $247.4M $132.2M $108.6M $72.07M $41.66M $38.09M $98.67M $113.7M $161.0M $36.60M $8.600M $2.600M $2.300M $3.100M $300.0K $1.100M $2.700M $1.500M
YoY Change
Accounts Payable $24.70M $41.74M $9.842M $7.434M $6.134M $4.880M $6.402M $7.061M $3.500M $5.600M $2.000M $500.0K $1.100M $500.0K $300.0K $500.0K $300.0K $800.0K
YoY Change -40.82% 324.1% 32.39% 21.19% 25.69% -23.77% -9.34% 101.75% -37.5% 180.0% 300.0% -54.55% 120.0% 66.67% -40.0% 66.67% -62.5%
Accrued Expenses $7.300M $3.451M $3.202M $3.488M $1.750M $1.823M $1.042M $1.682M $5.600M $1.000M $400.0K $300.0K $200.0K $200.0K
YoY Change 111.53% 7.78% -8.2% 99.31% -3.99% 74.98% -38.05% -69.97% 460.0% 150.0% 33.33% 50.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $22.60M $15.63M $14.86M $8.947M $6.597M $7.491M $5.236M $5.474M $2.000M $1.300M $0.00 $500.0K $500.0K $200.0K
YoY Change 44.56% 5.22% 66.07% 35.62% -11.93% 43.06% -4.34% 173.68% 53.85% -100.0% 0.0% 150.0%
Total Short-Term Liabilities $60.60M $41.74M $32.74M $24.39M $15.92M $14.27M $13.15M $14.97M $20.30M $18.90M $2.400M $800.0K $1.400M $700.0K $300.0K $2.600M $2.400M $1.800M
YoY Change 45.18% 27.5% 34.25% 53.18% 11.58% 8.52% -12.18% -26.25% 7.41% 687.5% 200.0% -42.86% 100.0% 133.33% -88.46% 8.33% 33.33%
Long-Term Debt $75.40M $10.93M $17.08M $18.89M $12.72M $8.873M $7.181M $5.753M $4.600M $4.300M $600.0K $500.0K $0.00 $0.00 $0.00 $0.00 $100.0K $500.0K
YoY Change 590.03% -36.03% -9.55% 48.5% 43.32% 23.57% 24.82% 25.06% 6.98% 616.67% 20.0% -100.0% -80.0%
Other Long-Term Liabilities $0.00 $133.0K $560.0K $0.00 $0.00 $9.294M $4.500M $100.0K $0.00 $0.00 $200.0K $400.0K
YoY Change -100.0% -76.25% -100.0% 4400.0% -100.0% -50.0%
Total Long-Term Liabilities $75.40M $10.93M $17.21M $19.45M $12.72M $8.873M $16.47M $5.753M $4.600M $4.300M $5.100M $600.0K $0.00 $0.00 $0.00 $200.0K $500.0K $500.0K
YoY Change 590.03% -36.52% -11.47% 52.91% 43.32% -46.14% 186.38% 25.06% 6.98% -15.69% 750.0% -100.0% -60.0% 0.0%
Total Liabilities $136.3M $52.67M $49.95M $43.83M $28.64M $23.14M $29.62M $20.72M $28.50M $24.00M $7.400M $1.500M $1.400M $700.0K $300.0K $2.900M $2.900M $2.400M
YoY Change 158.8% 5.44% 13.97% 53.06% 23.75% -21.88% 42.93% -27.28% 18.75% 224.32% 393.33% 7.14% 100.0% 133.33% -89.66% 0.0% 20.83%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Basic Shares Outstanding 42.50K 38.61K
Diluted Shares Outstanding 42.50K 38.61K
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $156.24 Million

About Quipt Home Medical Corp.

Quipt Home Medical Corp. engages in the provision of in-home monitoring and disease management services including end-to-end respiratory solutions. The company is headquartered in Wilder, Kentucky and currently employs 1,200 full-time employees. The company went IPO on 2014-03-18. The firm specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. The company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. The company offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The firm's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

Industry: Services-Misc Health & Allied Services, NEC Peers: AKUMIN INC. ATI Physical Therapy, Inc. Aveanna Healthcare Holdings, Inc. GeneDx Holdings Corp. CVS HEALTH Corp InfuSystem Holdings, Inc Talkspace, Inc.